Neovascular age-related macular degeneration

Disease5 papers1 finding

Human trial1
Humans1
In silico1

Associations

1

GLP-1 receptor agonists

upin humans1

1 study

GLP-1 receptor agonists are associated with neovascular age-related macular degeneration in humans.
Review
GLP-1 receptor agonists and ocular disease: Therapeutic promise, mechanistic insights and emerging safety signals · Drug discovery today · 24 Aug 2026

GLP-1 receptor agonists →

Trial sponsors

Genentech
Company1 trialPhase 4188 people

Latest

6

Journal of OphthalmologyReview20 Sep

Multivariable Prognostic Models for Age-Related Macular Degeneration: A Systematic Review

Age-related macular degeneration

Ophthalmology RetinaIn silico18 Sep

Global burden of age-related macular degeneration, with forecast up to 2050: a modelling study

Age-related macular degeneration

Ophthalmology RetinaHuman trial16 Sep

Ten-Year Survival of First-in-Human Autologous Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium Sheet Transplantation

Graefe's Archive for Clinical and Experimental OphthalmologyHumans14 Sep

Fellow-eye retinal age gap and high injection burden over four years in neovascular age-related macular degeneration

Investigative Ophthalmology & Visual ScienceAnimals25 Aug

Nicotinamide Mononucleotide Attenuates Inflammatory Activation, Choroidal Neovascularization, and Lesion-Associated Remodeling

Drug Discovery TodayReview24 Aug

GLP-1 receptor agonists and ocular disease: Therapeutic promise, mechanistic insights and emerging safety signals

GLP-1 receptor agonists